These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22782535)

  • 21. [New antithrombotic oligosaccharides].
    Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
    Ann Pharm Fr; 1999 May; 57(3):232-9. PubMed ID: 10427858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.
    Fonseca RJ; Santos GR; Mourão PA
    Thromb Haemost; 2009 Nov; 102(5):829-36. PubMed ID: 19888516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of specific inhibitors for heparin-binding proteins based on the cobra cardiotoxin structure: an effective synthetic strategy for rationally modified heparin-like disaccharides and a trisaccharide.
    Ke W; Whitfield DM; Brisson JR; Enright G; Jarrell HC; Wu WG
    Carbohydr Res; 2005 Feb; 340(3):355-72. PubMed ID: 15680590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new synthetic pentasaccharide with increased anti-factor Xa activity: possible role for anionic clusters in the interaction of heparin and antithrombin III.
    Petitou M; Lormeau JC; Choay J
    Semin Thromb Hemost; 1991; 17 Suppl 2():143-6. PubMed ID: 1948084
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP.
    Han F; Yao W; Yang X; Liu X; Gao X
    Int J Biol Macromol; 2005 Sep; 36(4):201-7. PubMed ID: 16102810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologic studies on chemically synthesized pentasaccharide and tetrasaccharide fragments.
    Choay J
    Semin Thromb Hemost; 1985 Apr; 11(2):81-5. PubMed ID: 4035368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfamate proton solvent exchange in heparin oligosaccharides: evidence for a persistent hydrogen bond in the antithrombin-binding pentasaccharide Arixtra.
    Langeslay DJ; Young RP; Beni S; Beecher CN; Mueller LJ; Larive CK
    Glycobiology; 2012 Sep; 22(9):1173-82. PubMed ID: 22593556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depiction of the forces participating in the 2-O-sulfo-alpha-L-iduronic acid conformational preference in heparin sequences in aqueous solutions.
    Pol-Fachin L; Verli H
    Carbohydr Res; 2008 Jul; 343(9):1435-45. PubMed ID: 18452898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulant activity of enzymatically synthesized amylose derivatives containing carboxy or sulfonate groups.
    Takahara J; Hosoya K; Sunako M; Hirohara S; Terada K; Ando T; Tanihara M
    Acta Biomater; 2010 Aug; 6(8):3138-45. PubMed ID: 20206721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide.
    Naggi A; Torri G; Casu B; Oreste P; Zoppetti G; Li JP; Lindahl U
    Semin Thromb Hemost; 2001 Oct; 27(5):437-43. PubMed ID: 11668413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analogues.
    Jeske W; Fareed J
    Semin Thromb Hemost; 1993; 19 Suppl 1():241-7. PubMed ID: 8362268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of Arg46 and Arg47 of antithrombin in heparin binding.
    Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of a 3-deoxy-L-iduronic acid containing heparin pentasaccharide to probe the conformation of the antithrombin III binding sequence.
    Lei PS; Duchaussoy P; Sizun P; Mallet JM; Petitou M; Sinaÿ P
    Bioorg Med Chem; 1998 Aug; 6(8):1337-46. PubMed ID: 9784873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of thrombin-inhibiting heparin mimetics without side effects.
    Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
    Nature; 1999 Apr; 398(6726):417-22. PubMed ID: 10201371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic heparin derivatives as new anticoagulant drugs.
    de Kort M; Buijsman RC; van Boeckel CA
    Drug Discov Today; 2005 Jun; 10(11):769-79. PubMed ID: 15922935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity.
    Choay J; Petitou M; Lormeau JC; Sinaÿ P; Casu B; Gatti G
    Biochem Biophys Res Commun; 1983 Oct; 116(2):492-9. PubMed ID: 6651824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 1.
    Quan ML; Liauw AY; Ellis CD; Pruitt JR; Carini DJ; Bostrom LL; Huang PP; Harrison K; Knabb RM; Thoolen MJ; Wong PC; Wexler RR
    J Med Chem; 1999 Jul; 42(15):2752-9. PubMed ID: 10425086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
    Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
    J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes.
    Tyler-Cross R; Sobel M; McAdory LE; Harris RB
    Arch Biochem Biophys; 1996 Oct; 334(2):206-13. PubMed ID: 8900394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.